<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="101863">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01778426</url>
  </required_header>
  <id_info>
    <org_study_id>1051</org_study_id>
    <nct_id>NCT01778426</nct_id>
  </id_info>
  <brief_title>Post-reimbursement Study to Follow Spinal Neurostimulator Devices for Pain Therapy (French SCS Registry)</brief_title>
  <acronym>SME</acronym>
  <official_title>Post-reimbursement Study to Follow Spinal Neurostimulator Devices for Pain Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medtronic International Trading Sarl</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medtronic Bakken Research Center</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Medtronic International Trading Sarl</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Observational study to evaluate the long term efficacy of Spinal Cord Stimulation (SCS) over
      2 years following SCS implant.

      This study is requested by French Health Authorities for reimbursement renewal, to maintain
      reimbursement for SCS in approved indication in France.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2012</start_date>
  <completion_date type="Actual">June 2016</completion_date>
  <primary_completion_date type="Actual">June 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>2 Years</target_duration>
  <primary_outcome>
    <measure>PainStim Efficacy</measure>
    <time_frame>2 years</time_frame>
    <description>Evaluate the percentage of patients with 50% decrease in the NPRS (Numeric Pain Rating Scale) score of the predominant pain over 2 years following SCS implant in first implant patients</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Safety</measure>
    <time_frame>2 years</time_frame>
    <description>Report all adverse device effects and procedure related adverse events over 2 years following SCS implant.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">414</enrollment>
  <condition>Chronic Pain Syndrome</condition>
  <arm_group>
    <arm_group_label>Patients with Medtronic neurostimulator</arm_group_label>
    <description>Patients suffering from chronic neuropathic pain syndrome implanted (first implant or replacements) with a Medtronic neurostimulator.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        All patients implanted (first implant or replacements) with a Medtronic neurostimulator in
        selected French sites .
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient indicated for Spinal Cord Stimulation (pain therapy)

          -  Patient implanted for less than 3 months or hospitalized for the implant of a
             Medtronic neurostimulator including:

          -  primary implant with Spinal Cord Stimulation indication and positive test of
             stimulation or

          -  device replacement of a Medtronic neurostimulator used for Pain Therapy

          -  Evaluation of usual pain in the back, upper and lower limbs using a visual analogic
             scale must be available for the 3 days preceding implant.

          -  Treatments must also be available

          -  Patient read and signed the data release form

        Exclusion Criteria:

          -  Patient declined participation

          -  Patient is not available for follow up

          -  Stimulation of other body part than spinal
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marie-Christine DJIAN, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Hôpital Saint Anne, Paris</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hôpital Foch - 40 rue Worth</name>
      <address>
        <city>Suresnes</city>
        <zip>92151</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <lastchanged_date>September 22, 2016</lastchanged_date>
  <firstreceived_date>January 24, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Chronic neuropathic pain syndrome</keyword>
  <keyword>Spinal Cord Stimulation</keyword>
  <keyword>Painstim devices</keyword>
  <keyword>Efficacy</keyword>
  <keyword>Safety</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Chronic Pain</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
